MedPath

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Phase 4
Completed
Conditions
Bradycardia
Interventions
Device: Closed Loop Stimulation (CLS)
Device: Standard Rate Adaptive (R) Technology
Device: Non-rate adaptive (DDD) pacing
Registration Number
NCT00355797
Lead Sponsor
Biotronik, Inc.
Brief Summary

This is a randomized, prospective, single-blinded, multi-center study involving approximately 1500 patients at 100 centers. The purpose of this study is to demonstrate the effectiveness of Closed Loop Stimulation (CLS) rate adaption technology over both standard rate responsive technology (R) and non-rate responsive mode (DDD) during activities of daily living (ADL).

Detailed Description

All patients enrolled in the CLEAR study are implanted with a Cylos pacemaker with Closed Loop Stimulation (CLS) rate adaption technology. Any legally marketed pacing leads may be implanted with the Cylos family of pacemakers.

Prior to enrollment, patients provide written informed consent and are screened to ensure they are eligible to participate in the study. Patients enrolled in the study must have been implanted within 45 days prior to enrollment or are being considered for implant. Once enrolled and implanted with the Cylos pacemaker, the first 500 patients have 45 days to complete an ADL Testing visit. At the Activities of Daily Living (ADL) testing visit, each of the first 500 enrolled patients performs a 6-minute walk test, orthostatic test, and sweep test in three pacing modes, CLS (DDD-CLS or VVI-CLS), standard rate response (DDDR or VVIR) and non-rate responsive mode (DDD or VVI). The order of the pacing modes for testing is randomized in a 1:1:1 ratio. The study primarily analyzes the number of ADL repetitions performed during the 6-minute walk and sweep tests, pulse pressure during the orthostatic test, and secondarily analyzes heart rates during all three tests to compare CLS to both rate responsive and non-rate responsive pacing modes.

For all enrolled patients, the study collects additional data over a 12-month period. Patients are randomized and their pacemaker programmed to one of three pacing modes, CLS, R, or no-rate response in a 2:1:1 ratio, respectively. The patients are then followed for a period of 12 months after the ADL testing (first 500 enrolled patients) or enrollment (patients 501 through 1500). The study collects the following secondary measures to compare CLS to both rate responsive and non-rate responsive pacing modes: changes in 6-minute walk test distance, quality of life, mode reprogramming, atrial fibrillation (AF) burden, cardiac symptoms, and New York Heart Association (NYHA) classification.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1491
Inclusion Criteria
  • Implanted within the last 45 days or being considered for implant with a BIOTRONIK pacemaker utilizing CLS rate adaptation technology (currently the Cylos family of pacemakers).
  • Ability to give written informed consent
  • Geographically stable and able to return for regular follow-ups for 12 months after ADL testing
  • At least 18 years old
Exclusion Criteria
  • Patients physically limited and unable to perform all or parts of the ADL testing
  • Currently enrolled in any other clinical study
  • Patients with medical reasons that preclude regular participation in the follow-ups

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Closed Loop Stimulation (CLS)Closed Loop Stimulation (CLS)Pacemaker programmed with Closed Loop Stimulation rate adaptive technology for long-term follow-up data collection.
Standard Rate Adaptive Technology (R)Standard Rate Adaptive (R) TechnologyPacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term follow-up data collection.
Non-rate adaptive pacing (DDD)Non-rate adaptive (DDD) pacingPacemaker programmed with no rate adaption (DDD mode) for long-term follow-up data collection.
Primary Outcome Measures
NameTimeMethod
Performance of Activities of Daily Living Tests (6-minute Walk and Sweep)within 45 days of enrollment

Six-minute walk test and sweep test results for subjects completing tests in all three pacing modes and requiring at least 80% pacing during both tests in the CLS and R pacing modes. The mean composite of repetitions (six minute walk plus sweep) are presented.

Pulse Pressure During Activities of Daily Living Tests (Orthostatic Test)within 45 days of enrollment

Patients completing the orthostatic test in all three pacing modes and that had at least 80% pacing during the test in the CLS and R pacing modes are included in the analysis. The mean pulse pressure is provided.

Secondary Outcome Measures
NameTimeMethod
Change in Quality of Lifebaseline and 12 months

Change in Quality of life (QOL) score was determined from baseline to the 12 month follow-up visit. The QOL utilized the physical functioning scale of the SF-36 v2, in which a higher score indicates a better health perception. Best possible score was 57.03 while the worst possible score was 14.94.

Mode Reprogramming12 months

Number of subjects with device reprogramming from dual (atrial and ventricular pacing) to single chamber (ventricular pacing only) or from single (ventricular pacing only) to dual chamber (atrial and ventricular pacing) during the 12 month follow-up.

Atrial Fibrillation (AF) Burden12 months

AF burden was measured at 12 months as the percentage of total atrial beats that are at or above 160 bpm.

Cardiac Symptoms12 months

Number of subjects exhibiting each cardiac symptom was determined at the 12 month follow-up visit.

Change in New York Heart Association (NYHA) Classbaseline and 12 months

Number of subjects with improved, no change, or worsened NYHA classification at the 12-month visit, as compared to baseline. NYHA classifications (I to IV) are used to assess the various stages of heart failure, with Class I relating to mild heart failure and Class IV relating to severe heart failure.

Change in 6-minute Walk Test Distancebaseline and 12 months

Change in number of 10 foot repetitions between baseline and 12-month visit were examined.

Trial Locations

Locations (96)

University of Chicago Medical Center

🇺🇸

Chicago, Illinois, United States

Dallas VA Medical Center

🇺🇸

Dallas, Texas, United States

New England Cardiovascular Specialists

🇺🇸

Boston, Massachusetts, United States

Boulder Medical Center

🇺🇸

Boulder, Colorado, United States

Western Cardiology Associates

🇺🇸

Englewood, Colorado, United States

Bluegrass Cardiology

🇺🇸

Louisville, Kentucky, United States

St. Louis Cardiology Consultants - Alton

🇺🇸

Alton, Illinois, United States

Zia Ahmad, MD, FACC

🇺🇸

St. Louis, Missouri, United States

Ochsner Clinic

🇺🇸

New Orleans, Louisiana, United States

Chand Medical Office

🇺🇸

Farmington, Missouri, United States

Amr El-Shafei, MD

🇺🇸

Mount Vernon, Illinois, United States

Melbourne Internal Medicine Associates

🇺🇸

Melbourne, Florida, United States

Brevard Cardiovascular Research Association

🇺🇸

Rockledge, Florida, United States

Southern Heart Group

🇺🇸

Jacksonville, Florida, United States

Doris Tummillo, MD

🇺🇸

Augusta, Georgia, United States

Alireza Jafari, MD

🇺🇸

Whittier, California, United States

Naeem Khan, MD

🇺🇸

Centralia, Illinois, United States

Space Coast Cardiology Consultants

🇺🇸

Port St. John, Florida, United States

Complete Cardiology Care

🇺🇸

New Smyrna Beach, Florida, United States

Cardiology Consultants, PA

🇺🇸

Pensacola, Florida, United States

Northside Cardiology, PC

🇺🇸

Atlanta, Georgia, United States

Collins Cardiology

🇺🇸

Douglas, Georgia, United States

Douglas Medical Specialists

🇺🇸

Douglas, Georgia, United States

Colorado Cardiovascular Center

🇺🇸

Boulder, Colorado, United States

Arizona Heart Institute

🇺🇸

Phoenix, Arizona, United States

Aurora Denver Cardiology Associates

🇺🇸

Denver, Colorado, United States

Minneapolis VA

🇺🇸

Minneapolis, Minnesota, United States

Cardiac Electrophysiology Consultants of S. Texas

🇺🇸

San Antonio, Texas, United States

Wasatch Cardiology Consultants, PC

🇺🇸

Salt Lake City, Utah, United States

Raymond Fernandez

🇺🇸

Albertville, Alabama, United States

Cardiology Associates-Gadsden

🇺🇸

Gadsden, Alabama, United States

North Alabama Cardiology Center

🇺🇸

Gadsden, Alabama, United States

Richard Kim, MD

🇺🇸

Jasper, Alabama, United States

Solano Cardiology

🇺🇸

Fairfield, California, United States

Family Doctor Medical Group

🇺🇸

Benicia, California, United States

N.R. Devaraj, M.D., Inc.

🇺🇸

Anaheim, California, United States

Multani Medical Group

🇺🇸

Downey, California, United States

Caremore Medical Group

🇺🇸

Downey, California, United States

Pacific Cardiology Associates

🇺🇸

Fremont, California, United States

Kenny Charn, MD

🇺🇸

Jackson, California, United States

San Joaquin General Hospital

🇺🇸

French Camp, California, United States

Kartik Thaker, MD

🇺🇸

Lakewood, California, United States

Mission Internal Medical Group

🇺🇸

Mission Viejo, California, United States

Cardio-Pulmonary Associates

🇺🇸

Monterey, California, United States

St. Luke Cardiovascular Medical Group

🇺🇸

Murrieta, California, United States

Emad Khaleeli, MD

🇺🇸

Torrance, California, United States

Torrance Memorial Medical Center

🇺🇸

Torrance, California, United States

Cardiology Consultants

🇺🇸

Turlock, California, United States

Ventura Cardiology

🇺🇸

Ventura, California, United States

West Michigan Cardiology

🇺🇸

Grand Rapids, Michigan, United States

Alfieri Cardiology

🇺🇸

Newark, Delaware, United States

Pidikiti Cardiology

🇺🇸

Corinth, Mississippi, United States

Thorasic and Cardiovascular Institute

🇺🇸

Lansing, Michigan, United States

Coast Heart Institute

🇺🇸

Gulfport, Mississippi, United States

Gateway Cardiology, PC

🇺🇸

St. Louis, Missouri, United States

Liberty Cardiovascular Specialists

🇺🇸

Liberty, Missouri, United States

Midwest Health Professionals, P.C.

🇺🇸

Bridgeton, Missouri, United States

Cardiac Specialists of St. Lukes

🇺🇸

Crystal City, Missouri, United States

Manzoor Tariq, MD

🇺🇸

Festus, Missouri, United States

Lake Cardiovascular Institute, P.C.

🇺🇸

Osage Beach, Missouri, United States

Heartland Medical Associates, LLC

🇺🇸

Moberly, Missouri, United States

White Sands Institute for Clinical Research

🇺🇸

Las Cruces, New Mexico, United States

St. Louis Heart and Vascular, P.C.

🇺🇸

St. Louis, Missouri, United States

Abbas Shehadeh, MD, FACC

🇺🇸

West Orange, New Jersey, United States

St. Louis Cardiovascular Center

🇺🇸

St. Louis, Missouri, United States

St. Louis Cardiology Center, P.C.

🇺🇸

St. Louis, Missouri, United States

Heart Group of the Carolinas

🇺🇸

Concord, North Carolina, United States

Ohri Medical Group, P.C.

🇺🇸

Warsaw, New York, United States

Carolina Heart Care

🇺🇸

Elkin, North Carolina, United States

Carolina Heart Specialists

🇺🇸

Lancaster, South Carolina, United States

University Hospitals Case Medical Center

🇺🇸

Cleveland, Ohio, United States

Piedmont Cardiology

🇺🇸

Hickory, North Carolina, United States

Toledo Clinic Cardiology

🇺🇸

Toledo, Ohio, United States

Westside Cardiology Associates, Inc.

🇺🇸

Fairview Park, Ohio, United States

Oklahoma Heart Institute

🇺🇸

Tulsa, Oklahoma, United States

Bryan Lucenta, MD

🇺🇸

Tulsa, Oklahoma, United States

Lakshmi Mizin, M.D.

🇺🇸

Carbondale, Pennsylvania, United States

Alderfer & Travis Associates

🇺🇸

Sellersville, Pennsylvania, United States

Carolina Heart and Vascular Center

🇺🇸

Aiken, South Carolina, United States

South Carolina Heart Center

🇺🇸

Columbia, South Carolina, United States

Pee Dee Cardiology

🇺🇸

Florence, South Carolina, United States

Carolina Cardiology Associates

🇺🇸

Rock Hill, South Carolina, United States

Heart Rhythm Specialists of East Tennessee

🇺🇸

Knoxville, Tennessee, United States

Cardiology Care Consultants

🇺🇸

El Paso, Texas, United States

Fort Worth Heart

🇺🇸

Fort Worth, Texas, United States

Lone Star Arrhythmia and Heart Failure Center

🇺🇸

Amarillo, Texas, United States

Cardiology Associates of West Texas

🇺🇸

San Angelo, Texas, United States

Waukesha Heart Institute

🇺🇸

Waukesha, Wisconsin, United States

Daniel Gottlieb

🇺🇸

Burien, Washington, United States

Lalit Chouhan, MD

🇺🇸

St. Louis, Missouri, United States

Sacramento Heart & Vascular

🇺🇸

Sacramento, California, United States

Tulane University Medical Center

🇺🇸

New Orleans, Louisiana, United States

Cardiovascular Associates of Virginia

🇺🇸

Richmond, Virginia, United States

McGuire VA Medical Center

🇺🇸

Richmond, Virginia, United States

Charleston Cardiology

🇺🇸

Charleston, South Carolina, United States

Austin Cardiac Clinic

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath